CCIT-DK - National Center for Cancer Immune Therapy of Denmark

📣 What a Ph.D. student needs to know about Cancer Immunology and Immunotherapy, all in one course. Register now to secure your spot! ▶ WHAT: PhD course "Cancer Immunology and Immunotherapy", 4th edition 📃 Course Description 👉 https://lnkd.in/dnpC9J4E ▶WHEN: 07/04-2025 (monday) to - 11/04/2023 (friday) ▶WHERE: Herlev, Denmark (Herlev Medborgerhus https://lnkd.in/eWh9GW4d and Herlev Hospital https://lnkd.in/ehRUR3dF) ✔ Register at: https://lnkd.in/dnpC9J4E 📩 Full program available soon! Program of the previous edition available at https://lnkd.in/dwrfDqS8 (info on the previous course at https://lnkd.in/eNYAkn8m) The course is organized by CCIT-DK - National Center for Cancer Immune Therapy of Denmark (course director: Marco Donia), on behalf of the University of Copenhagen (Københavns Universitet) If you are a PhD student at any University in Denmark, you can register free of charge. All other categories can register for a fee. Contact us (course secretary Mette Wassard Yde or Marco Donia) if you need more information.

Advancing Melanoma Treatment with T Cells 🧬🧬 In a conversation with Søs Egelind in the #KnækCancer Liveshow, our Professor Inge Marie Svane discussed the transformative potential of T cells in treating melanoma Cancer - and how it has potential to help many patients in the future. 📺 Watch the interview here 👉 https://lnkd.in/dm5GYZuy (starts at 24:07, login required) Thank you to Kræftens Bekæmpelse for funding our research 🙌 #KnækCancer #DKForsk #Cancer #Oncology

Our Director, Mads Hald Andersen was invited to present a seminar at the Dana-Farber Cancer Institute of Harvard Medical School. His talk focused on immune modulatory vaccines, specifically how anti-regulatory T cells can directly and indirectly target suppressive regulatory cells, and the potential benefits of adding tumor microenvironment antigens to neoepitope-based cancer vaccines. We sincerely thank the NeoVax team at Dana-Farber, with special appreciation to Derin Keskin for the invitation and the campus tour

Are you curious about how we work with T cells? 🧬 This morning our head of Cell Therepy Unit, Dr. Özcan Met was in Go' Morgen Danmark to explain how we use T cells to impove the treatment of melanoma patients. 📺Watch it here 👉 https://lnkd.in/dvJghqpC Thank you to Kræftens Bekæmpelse for funding our research 🙌 #KnækCancer #DKForsk #Cancer #Oncology

Thank you to Kræftens Bekæmpelse and #KnækCancer for funding our reserach 🙏

VIL DU VÆRE MED TIL AT GØRE EN FORSKEL FOR BEHANDLINGEN AF KRÆFTPATIENTER? 🔬 🧬 Celleterapi-enheden søger en ny bioanalytiker eller laborant til at indgå i GMP-teamet 👩🔬 👨🔬 Teamet producerer lægemidler til de kliniske forsøg, der udføres på CCIT-DK - National Center for Cancer Immune Therapy of Denmark. Dette inkluderer GMP-fremstilling af blandt andet tumor-infiltrerende lymfocytter fra kræftvæv, genetisk modificerede T celler og peptidvacciner til patientbehandling 🧫Derudover varetager GMP-gruppen også flere kvalitetsanalyser relateret til GMP-fremstillingerne samt præparering af blodprøver og nedfrysning af immunceller fra forskningsprojekter 📊 Så er du uddannet bioanalytiker eller laborant og har du lyst til at være med til at gøre en forskel for kræftpatienter? Følg linket og søg👇 https://lnkd.in/dMTpZX83 Ansøgningsfrist 8. november 2024.

Starting XXI NIBIT Meeting with Inge Marie Svane from Copenaghen University Hospital kicking off the "Cellular therapies: present and future" session. She discussed adoptive T-cell Therapy for metastatic melanoma

📢 CCIT PhD Students Attend Summer School on Translational Cancer Research 🌍 Two of our PhD students, Lucía Lara de la Torre Lara de la Torre and Emilie Bülow Jensen, recently participated in the Cancer Core Europe Summer School in Translational Cancer Research in Algarve, Portugal. During this five-day program, they participated in lectures, hands-on workshops, and networking opportunities with researchers and fellow PhD students from across Europe. Key topics explored included: 💡 AI in cancer research 🔍 Biomarkers 🧍🏽 Patient-centered approaches 🖥️ Omics data 🧪 Translating research from bench to bedside—and back In addition to expanding their knowledge, they also had the chance to present their research projects through poster sessions, which led to meaningful discussions with fellow researchers and peers. A special thanks to Cancer Core Europe for organizing this insightful program and promoting collaboration within the cancer research community. #CCESumSchool24 

📣 PhD Defense, Anne Rahbech 👏 Congratulations to Anne Rahbech on successfully defending her PhD thesis, "Pre-clinical examination of functional aspects of T cells for adoptive cell therapy ."   📑 Anne has been part of the research at CCIT-DK - National Center for Cancer Immune Therapy of Denmark under the supervision of Per thor Straten. 🙏 We would like to thank the assessment committee for their insightful evaluation and valuable feedback: ◾ Manja Idorn Haugum, Department of Biomedicine, Aarhus University, Denmark ◾ Andreas Lundqvist, Department of Oncology-Pathology, Karolinska Institutet, Sweeden ◾ Chairman: Søren Skov, Department of Veterinary and Animal Sciences, University of Copenhagen, Denmark Denmark.

👏 Congratulations to Rikke Boedker Holmstroem for successfully defending her PhD thesis, which is entitled "Adjuvant immunotherapy in melanoma and management of immunotherapy-induced toxicity" 👏